KITS USE GENE

Brand Owner Address Description
DOVETAIL GENOMICS Dovetail Genomics 100 Enterprise Way, Suite A101 Scotts Valley CA 95066 kits for use in gene analysis and sequencing as well as DNA analysis and sequencing; kits for use in collection, storage and preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing;DOVE TAIL GENOMICS;chemical test kits for use in gene analysis and sequencing as well as DNA analysis and sequencing for laboratory or research use;gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment;GENOMICS;research of agriculture; scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A new gene-MN-and proteins/polypeptides encoded therefrom are disclosed. Recombinant nucleic acid molecules for expressing MN proteins/polypeptides and recombinant proteins are provided. Expression of the MN gene is disclosed as being associated with tumorigenicity, and the invention concerns methods and compositions for detecting and/or quantitating MN antigen and/or MN-specific antibodies in vertebrate samples that are diagnostic/prognostic for neoplastic and pre-neoplastic disease. Test kits embodying the immunoassays of this invention are provided. MN-specific antibodies are disclosed that can be used diagnostically/prognostically, therapeutically, for imaging, and/or for affinity purification of MN proteins/polypeptides. Also provided are nucleic acid probes for the MN gene as well as test kits comprising said probes. The invention also concerns vaccines comprising MN proteins/polypeptides which are effective to immunize a vertebrate against neoplastic diseases associated with the expression of MN proteins. The invention still further concerns antisense nucleic acid sequences that can be used to inhibit MN gene expression, and polymerase chain reaction (PCR) assays to detect genetic rearrangements.